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Abstract
Background: Tuberculosis (TB) in children is neglected, mainly due to lack of sensitive diagnostic tools. Recently
Xpert MTB/RIF assay has revolutionized the diagnostic field, but its usefulness in pediatric TB has not been reported
from India and no report is available on its use on long term archived samples.
Methods: We recruited 130 pediatric patients with probable intrathoracic tuberculosis and their gastric aspirate
(GA) and induced sputum (IS) samples on 2 consecutive days were collected between January 2009 and December
2012. All samples (n = 520) were subjected to smear examination, BACTEC-MGIT culture and in-house multiplex PCR.
An aliquot of each sample was stored at −80 °C and tested in Xpert MTB/RIF assay in 2013.
Results: Sample wise and patient wise detection rate of smear microscopy was 4.4 % and 10 %, while for BACTEC-MGIT
culture this rate was 24.4 % and 46.9 %, respectively. Of the 130 day 1 GA samples, 31.5 % and 27.7 % day 2 GA samples
were culture positive. Only 17.7 % GA samples were positive on both days. Of the 130 IS samples collected on day 1
and day 2, 15.4 % and 23.1 % samples were culture positive. A combination of GA and IS yielded best results.
Combining both GA and IS, the overall sensitivity of Xpert MTB/RIF on smear and culture positive samples was
95.6 %. In smear negative and culture positive samples its sensitivity was 62.5 %. The duration of sample storage
impacted the Xpert MTB/RIF test performance (p = 0.0001). In smear positive samples stored for 650–849 days, its
sensitivity was 85.7 % and 77.1 % for IS and GA samples which dropped to 33.3 % and 50 %, respectively, if stored for
more than 1050 days.
Discussion: Confirmatory diagnosis of tuberculosis particularly in children is a medical challenge. No laboratory or
radiological test can reach to a satisfactory level of diagnostic sensitivity. However, in this study we foundthat
combination of multiple samples and multiple diagnostic tests can give much better yield, though notoptimum. In
present study, combination of 2 gastric aspirates (GA) and 2 induced sputum (IS) samples collected on two consecutive
days, and tested on three diagnostic methods yielded a significantly high detection rate. Despite long term storage,
the overall sensitivity of Xpert MTB/RIF on smear and -culture positive samples remained very high. But after storing
these samples under subfreezing conditions thesensitivity of Xpert MTB/RIF decreased significantly. This is expected
because even if the sample is smear and culture positive, the count of surviving mycobacteria goes down, after several
years this count can reach to a undetectable level.
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Conclusion: This report shows that smear and culture positive samples stored at subfreezing conditions for several
years can be used in the Xpert MTB/RIF assay, while maintaining appreciable diagnostic test sensitivity and specificity.
Keywords: Pediatrics Tuberculosis, India, Gastric Aspirate, Induced Sputum, Archived Samples, mPCR, MGIT Culture,
Xpert MTB/RIF
Background
World Health Organization (WHO) estimated the global
burden of tuberculosis (TB) at 9 million new cases and
1.5 million deaths in 2013 [1]. This included up to 15 %
burden of pediatric cases. About 74,000 children die of
TB every year and there are around half a million new
cases annually [2]. Like in adults, the majority (70–80 %)
of child TB cases present with pulmonary tuberculosis
(PTB). Tuberculosis in children has been relatively
neglected, mainly due to challenges in the availability of
effective diagnostic tools [3]. India is 17th among 22
high burden countries in terms of overall TB incidence
rate, but very little information is available regarding
epidemiology of TB in children, its diagnosis and
management [4, 5].
In most settings diagnosis of pediatric TB is made on
the basis of contact tracing, and very few attempts have
been made for active case detection. This is mainly due to
lack of a pathognomonic clinical presentation in pediatric
TB and lack of sensitive diagnostic tools [3, 4, 6, 7].
With limited tools for confirmatory laboratory diagno-
sis, evaluation of medical history, tuberculin skin testing,
chest x-ray and a lack of response to antibiotics help in
making the clinical diagnosis. Smear microscopy and
microbiological confirmation is rarely achieved due to
poor sensitivity of these tests, in part due to the pauciba-
cillary nature of the disease and inability of young chil-
dren to provide an optimal sputum sample [6]. Alternate
samples include gastric aspirate (GA), induced sputum
(IS), nasopharyngeal aspirate, bronchio-alveolar lavage,
laryngeal swab, string test and stool samples [3, 7–10].
Depending on the diagnostic test used, these samples
have shown variable sensitivity and specificity. It has
been reported that gastric lavage samples provide the
highest (40–92 %) detection rate, depending on the
sensitivity of the laboratory test adopted. Other sam-
ples have shown poorer detection rates ranging from
4–43 % for bronchoalveolar lavage, 24–30 % for
nasopharyngeal aspiration, 27–63 for laryngeal swab
and 20–30 % by using induced sputum. Some
workers have also used string test but results have
not been encouraging [3, 7, 11–13].
The recent introduction of the Xpert MTB/RIF assay
(Cepheid, USA) has significantly transformed the diag-
nostics of tuberculosis in adults, but its application for
the diagnosis of pediatric TB is under evaluation. This
assay is rapid and provides results within 2 h [14]. In a
policy statement World Health Organization (WHO) in
2011, recommended the use of Xpert MTB/RIF assay as
a preliminary diagnostic tool among children, in adults
with suspected human immunodeficiency virus (HIV)
associated tuberculosis and in all MDR TB suspected
cases [15]. Subsequently, several workers have started
using Xpert MTB/RIF assay for the diagnosis of pediatric
tuberculosis [10, 16–18]. However, the wide spread use
of Xpert MTB/RIF for the diagnosis of pediatric TB on a
routine basis still remains a distant option. To date,
there are only a few studies on the application of the
Xpert MTB/RIF for the diagnosis of pediatric TB. Two
studies report on the use of the Xpert MTB/RIF on in-
duced sputum two on its use in gastric lavage samples.
There are no studies that report on use of Xpert MTB/
RIF in both GA and IS samples simultaneously on the
same patient. Further, there is no study from India on the
evaluation of Xpert MTB/RIF for the diagnosis of
pediatric pulmonary TB. Moreover, the utility of Xpert
MTB/RIF on archived GA and IS samples has previously
not been examined. Since the Xpert MTB/RIF became
available only after 2011, there is no other rapid test which
can detect TB and RIF resistance simultaneously in sam-
ples which were collected before 2011. This study also ex-
amines the effect of long term storage of clinical samples
on for the detection of TB by the Xpert MTB/RIF assay.
We have earlier reported that GA samples provide
better yields than IS samples [19]. In a subsequent report
we also showed that neutralizing the pH of gastric aspirate
before processing leads to a higher rate of contamination
without improving the detection rate [20]. In the present
study we report on the performance of the Xpert
MTB/RIF on archived GA and IS samples collected
on two consecutive days from children with probable
intrathoracic TB, recruited as part of a double
blinded randomized controlled trial to study the role
of micronutrient supplementation in children with
intra-thoracic tuberculosis.
Methods
Study design and subject recruitment
The study was conducted between January 2009 to
December 2012 at the All India Institute of Medical
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Sciences (AIIMS) and Kalawati Saran Children’s Hospital
(KSCH), both in New Delhi, India. This work was part
of a double blinded randomized controlled trial to study
the role of micronutrient supplementation in children
with intra-thoracic tuberculosis [19–22]. A total of 403
children (58.2 % girls), aged between 6 months to
14 years [Median age, 120 months; interquartile range
(IQR), 7–168 months], with probable intra-thoracic TB
were enrolled. The standard clinic-radiological criteria
for suspecting intra-thoracic tuberculosis was used in
this study as published earlier [19–22]. The diagnosis of
intrathoracic tuberculosis was based on recommenda-
tions of Indian Academy of Pediatrics. Any child with
cough and fever of more than 2 weeks with no improve-
ment during seven to ten days amoxicillin course and re-
cent unexplained weight loss or history of contact with
TB patient in past two years. All tuberculosis suspects
underwent a chest x-ray (lateral and posterior-anterior).
In presence of persistent x-ray abnormalities, with non-
resolution of clinical symptoms and no alternative cause
for symptoms and chest x-ray findings, a probable diagno-
sis of intrathoracic tuberculosis was made. All children
with probable tuberculosis were subjected to tuberculin
skin test (TST), ambulatory gastric aspirates (GA) and
induced sputum (IS) examination for AFB smear and
culture. Children were started on ATT as per recom-
mendations of the RNTCP [5]. In brief: All children
with probable intra-thoracic tuberculosis were subjected
to gastric aspiration (GA) and induced sputum (IS) collec-
tion for two consecutive days (D1 & D2). Children were
asked to report 6 h fasting in the morning to the desig-
nated clinic. After explaining the procedure and obtaining
consent from parents and verbal assent from the children,
an appropriate sized feeding tube (10-12G) was inserted
through one nostril till it reached the stomach. The pos-
ition of tube was checked by insufflation of air into stom-
ach. The contents of stomach were aspirated completely,
kept in sterile container. Usual volume collected was
around 10 ml. Samples were transported to laboratory for
further processing within 1–2 h.
In the same sitting gastric aspiration was followed by
induced sputum with a gap of around half hour. For
sputum induction, the child was primed with 2 puffs sal-
butamol inhalation by metered dose inhaler (MDI Asth-
alin,100 μg/puff, Cipla, India)) and spacer (Zeroastat VT
spacer, Cipla, India) followed by nebulization with 3 mL
of 3 % saline over next 15–20 min. All samples were
given unique code numbers; and sent to the laboratory
without a link to clinical and patient details. Samples
were processed on the same day for AFB smear,
BACTEC-MGIT culture and in-house PCR [23]. Clinical
and other patient details were recorded in excel sheet by
treating pediatrician and the laboratory was not aware of
the clinical diagnosis of the subjects.
Ethical considerations
The study was approved by Institutional ethics commit-
tee of All India Institute of Medical Sciences, New Delhi
and Kalawati Saran Children Hospital, New Delhi, India,
and the trial was registered at clinicaltrials.gov (NCT
00801606). Written informed consent was obtained from
parents/guardians of each child.
Laboratory methods
Sample processing
IS and GA (pH non-neutralized) samples were processed
as described previously [19, 21, 23, 24]. In brief, the sam-
ples were centrifuged at 10,000 x g for 10 min, at 4 °C;
supernatant decanted and pellet was re-suspended in an
equal volume of 0.5 % NALC–4 % NaOH mixture in
50 ml ridge capped round bottom processing tubes. The
suspension was thoroughly (4 x 10 s each interval) vor-
texed to ensure proper mixing and was incubated at 37 °C
for 10 min. After incubation, alkaline pH was neutralized
with phosphate buffer [PBS (pH 6.8, total volume of
50 ml)] followed by final centrifugation at 10,000 x g for
10 min, at 4 °C. The supernatant was decanted; the pellet
re- suspended in 2 ml of the PBS and 0.5 ml volume ali-
quoted in 4 sterile tubes. One aliquot was used for smear
preparation, one for culture and another for testing in an
in-house multiplex PCR (m-PCR). One aliquot was stored
at −80 °C for further use. From one aliquot, a 500 μl
suspension was inoculated in BACTEC MGIT-960 liquid
culture system (BACTECTM MGIT, Becton Dickinson,
Sparks, USA), using the standard protocol [25]. Irrespect-
ive of a positive or a negative flashed result, all cultures
were examined by Ziehl-Neelsen staining. Differentiation
of isolates into Mycobacterium tuberculosis (MTB) or
non-tuberculous mycobacteria (NTM) was undertaken by
a species specific in-house m-PCR [23]. The IS and GA
sample aliquots, stored at −80 °C, were retrospectively
examined in the Xpert MTB/RIF assay.
Xpert MTB/RIF Test
In 2013, the stored samples were subjected to Xpert
MTB/RIF testing. There were 520 decontaminated GA
and IS paired samples (130x2 GA & 130x2 IS) that were
suitable for testing, while others were either not suffi-
cient in quantity or quality (contaminated). The sample
reagent buffer containing NaOH and isopropanol was
added in the ratio of 3:1 (total 2 ml), and incubated for
15 min at room temperature. The treated sample (2 ml)
was then transferred into the Xpert MTB/RIF cartridge
containing the wash buffer, lyophilized reagents for
DNA extraction and PCR amplification. After proper
mixing, the cartridge was loaded in the Xpert MTB/RIF
instrument, as per the manufacturer’s instructions
(Cepheid, USA). The instrument performs specimen
mixing, sonication of the mycobacterial bacilli and
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internal control (spores), DNA release and mixing
with the PCR reagents, automatically. This is followed
by a hemi-nested real time-PCR amplification, target
detection by five-color fluorescence molecular beacon
probes and internal control in-situ. Results are generated
after 2 h and reported as M. tuberculosis - negative or
positive with semi-quantified bacillary load as high,
medium, intermediate or low and if the pathogen is RIF
sensitive or resistant [14]. The patient details were linked
to the samples tested only after completion of the Xpert
MTB/RIF evaluation.
Statistical analysis
Sensitivity of Xpert MTB/RIF was determined by consid-
ering MGIT culture confirmed samples as true positive.
To determine the specificity of Xpert MTB/RIF, smear,
MGIT culture and in-house m-PCR negative samples
were considered as true negative samples. Positive pre-
dictive values (PPV), negative predictive value (NPV)
and likelihood ratio for positive (LRP) Xpert MTB/RIF
were calculated with 95 % CI (confidence intervals). LRP
of greater than one indicates that the test result is most
likely true positive and less than one means that the test
result is likely true negative [26]. Pearson chi square test
was performed for comparison of patient wise analysis.
To rule out the proportion of agreement by chance,
Cohen’s kappa test was used. A p-value of <0.05.was
considered statistically significant [STATA 11.0 (college
station, Texas, USA) software was used for all statistical
analysis].
Results
In this study, conducted between January 2009 to
December 2012. A total of 403 children (58.2 % girls),
aged between 6 months to 14 years [Median age,
120 months; interquartile range (IQR), 7–168 months],
with probable intra-thoracic TB were enrolled. Only
those children were included from whom both GA and
IS samples collected on two consecutive days were
available. Therefore, paired IS and GA samples obtained
on two consecutive days from 130 children were analysed
by Xpert MTB/RIF assay. The decontaminated samples
were stored at −80 °C for 21.4 to 51.9 months (median
storage period 32.5 months; IQR 27–35.1) before these
were subjected to Xpert MTB/RIF analysis. The laboratory
workflow and summary of results are shown in Fig. 1.
Diagnostic outcome of IS and GA samples collected on
two consecutive days
Only 23 out of 520 (4.4 %) samples from 13 (10 %)
children were AFB smear positive (Fig. 1). Of these
23 samples, 9 were D1 and 8 were D2 GA samples.
Second day (D2) GA samples detected 3 additional
AFB smear positive cases while it missed 4 cases which
were positive on D1, hence there was no net incremental
value from a D2 GA sample. Only 3 IS samples were posi-
tive on either D1 or D2. The D2-IS sample added one case
but also missed one case. Sixty one out of 130 (46.9 %)
children [127 of 520 (24.4 %) samples] were diagnosed to
have culture confirmed tuberculosis either by smear or
culture (Table 1). Out of 130 D1-GA samples 41 (31.5 %)
Fig. 1 Flow chart depicting the inclusion of samples with flow of sample processing, methods used and results as per STROBE guidelines
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while 36 (27.7 %) of D2-GA samples were culture positive.
Twenty three (17.7 %) children had a culture positive GA
on both days (Table 2). The yield from induced sputum
samples was poor. Of 130 IS samples collected on D1,
only 20 samples (15.4 %) were positive while on D2, 30
(23.1 %) samples were culture positive (Table 3). Sixteen
(12.3 %) children had a culture positive IS on both days.
The MGIT culture yields from GA and IS samples col-
lected on two consecutive days is shown in (Tables 2 & 3,
respectively). There was no additional value of a second
day GA sample for smear microscopy (9 vs 8), culture (41
vs 36), or Xpert MTB/RIF assay (33 vs 34). However, IS
samples collected on two consecutive days provided a
significant additional value in culture (20 vs 30) but an in-
significant additional increment in the Xpert MTB/RIF
assay (22 vs 25). A combination of one GA and one IS
sample gave best diagnostic utility, irrespective of D1 or
D2. Almost, 50 % samples (either GA or IS) were Xpert
MTB/RIF positive on both days (Fig. 2).
Comparison of IS and GA
Overall, in samples (IS + GA) which were positive either
in smear and/or culture (127/520), the sensitivity of
Xpert MTB/RIF assay was slightly lower (68.5 %, 87/127)
as compared to bacteriological examination (Table 1) but
it also detected 7.9 % (31/393) additional cases over the
culture giving an overall sensitivity of 22.7 % [118/520]
(p = NS) but significantly higher (p = 0.001) sensitivity
than smear microscopy (Table 4). The performance of
Xpert MTB/RIF was 95.6 % (22/23) on smear and cul-
ture positive archived samples, as shown in (Table 1)
and flow chart (Fig. 1). All 14 samples that yielded
NTM species were smear negative but culture and m-
PCR positive. Hence on re-evaluation, the sensitivity of
Xpert MTB/RIF on smear negative but culture positive
(MTB only) samples was 72.2 % (65/90). But if all culture
positive samples were taken together without considering
the mycobacterial species, the sensitivity fell down to
62.5 % (65/104) due to 14 NTM isolates. The sensitivity of
Xpert MTB/RIF did not differ much between the GA and
IS samples if all bacteriologically (smear and /or culture)
positive GA (92.2 %, 71/77) and IS (94 %, 47/50) samples
were compared. No NTM positive sample was falsely
identified by Xpert MTB/RIF but it missed one smear, cul-
ture and m-PCR positive sample, the isolate was identified
as MTB by m-PCR and . All Xpert MTB/RIF positive
samples were also m-PCR positive. Hence our in-house
m-PCR and Xpert MTB/RIF showed 100 % concordance
in NTM/MTB differentiation (Fig. 1).
Comparison of Xpert MTB/RIF, Culture and AFB smear
microscopy
Xpert MTB/RIF assay detected an additional 31 of 393
(7.9 %) samples which were both AFB smear and MGIT
culture negative but missed 39 of 104 (37.5 %) culture
positive samples (Table 4). In children with probable in-
trathoracic tuberculosis, gastric aspirate identified more
cases than induced sputum using smear microscopy,
Table 1 Performance of Xpert MTB/RIF assay in bacteriologically positive and bacteriologically negative samples [combination of
gastric aspirates (n = 260) and induced sputa (n = 260)] collected from children with probable intrathoracic tuberculosis
Bacteriological criteria (N = 520) Sub-criteria No. (%) Xpert MTB/RIF Results
Positive (%) Negative (%)
Bacteriologically positive (n = 127; 24.4 %) Smear (+), culture (+) 23 (4.4)*, ** 22 (95.7) 1 (4.3)
Smear (−), culture (+) 104 (20)* 65 (62.5) 39 (37.5)
Smear (+), culture (−) 0 0 0
Subtotal 127 87 (68.5) 40 (31.5)
Bacteriologically negative (n = 393; 75.5 %) Smear (−), culture (−) 393 31 (7.9) 362 (92.1)
Total 520 118 (22.7)** 402 (77.3)
The table shows high efficacy of Xpert MTB/RIF in culture and smear positive samples but moderate detection rate in smear negative culture positive samples
*,** P < 0.001, (+)- positive, (−)- Negative, number in parenthesis indicate percentage
Table 2 Performance of MGIT 960 culture on gastric aspirate
samples collected on two consecutive days from 130 children
with probable intrathoracic tuberculosis
MGIT960 Culture
Results
Day 1
Positive Negative Total
Day 2 Positive 23 (17.7 %) 13 (10 %) 36 (27.7 %)
Negative 18 (13.8 %) 76 (58.5 %) 94 (72.3 %)
Total 41 (31.5 %) 89 (68.5 %) 130
Table 3 Performance of MGIT 960 culture on induced sputum
samples collected on two consecutive days from 130 children
with probable intrathoracic tuberculosis
MGIT 960 Culture
Results
Day 1
Positive Negative Total
Day 2 Positive 16 (12.3 %) 14 (10.8 %) 30 (23.1 %)
Negative 4 (3.1 %) 96 (73.8 %) 100 (76.9 %)
Total 20 (15.4 %) 110 (84.6 %) 130
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culture and Xpert MTB/RIF assay (6.5, 29.6, and 27.3 %
vs 2.3, 19.2 and 18.0 %, respectively). Yield of Xpert
MTB/RIF assay decreased with increasing duration of
storage of GA as well as IS samples. In samples stored
for 650–849 days, the detection rate of Xpert MTB/RIF
assay on IS samples was 85.7 % which dropped to 33.3 %
in samples stored for more than 1050 days. Similarly,
these rates were 77.1 and 50 %, respectively in GA sam-
ples (Fig. 3). After long storage difference in the yield of
IS and GA was highly significant (P = 0.002).
Discussion
There has been a flow of publications on Xpert MTB/
RIF also known as GeneXpert or cartridge based nucleic
acid amplification testing (CBNAAT) in the last 3 years.
This is the first study from India on the use of the Xpert
MTB/RIF assay in children with intrathoracic TB and
also the first study to report on the utility of this assay
on archived GA and IS samples from children in TB en-
demic country. The study shows that even in GA and IS
samples stored for up to 4 years, the Xpert MTB/RIF
assay remained useful as a diagnostic tool for childhood
tuberculosis. In GA and IS samples which were smear
and culture positive, the sensitivity of Xpert MTB/RIF
assay was 95.6 %, which is similar to that reported in
fresh clinical samples. As expected the sensitivity of
Xpert MTB/RIF was superior to that of smear microscopy
(p = 0.0001). However, the sensitivity of Xpert MTB/RIF
assay on culture positive but smear negative samples was
lower (62.5 %). Performance of Xpert MTB/RIF assay has
previously been evaluated mostly on sputum samples
collected from adult TB patients [27–30], showing a
high sensitivity in smear and culture positive samples
(98–100 %) but a much lower sensitivity in smear
negative sputum samples (43–70 %). Our findings
were also similar to these findings, but on archived
samples. A lower sensitivity of the Xpert MTB/RIF
assay has also been reported in HIV positive adult patients
[29]. There are few studies that have been conducted in
children and a very few where performance of Xpert
MTB/RIF assay has been evaluated on samples other than
sputum samples [4–10, 30, 31]. Nicol et al. [8] included
452 children for analysis with at least one IS sample from
each child. They also showed a poor sensitivity of micros-
copy (6 %), culture (16 %) and Xpert MTB/RIF assay
(13 %) in these samples. In the present study, though
detection rates of these three methods were higher but the
pattern was similar. Since we examined both IS and GA
samples on two consecutive days, on comparison the yield
from IS samples was much lower than gastric aspirate
samples. Though there is no data published so far in
which both GA and IS samples have been used in the
same study to evaluate the sensitivity and specificity of
Xpert MTB/RIF assay in clinically probable cases of intra-
thoracic tuberculosis, yet our results were in total con-
cordance with findings of Bates et al. [10], Rachow et al.
[16] and Sekadde et al. [17]. Our study shows that smear
and culture yields in GA samples are superior to those of
IS samples, however, the sensitivity of Xpert MTB/RIF
assay was not significantly different in GA and IS samples,
in samples stored at −80 °C for the same duration (77.1
and 85.7 %, respectively; P = 049). Furthermore, we
collected both these samples on two consecutive days,
and this protocol slightly provided better yield in all
diagnostic techniques i.e. smear, culture and Xpert MTB/
RIF assay. Because of this double pronged approach, we
could achieve a high diagnostic {61 of 130; 46.9 % children
(per patient analysis)} yield.
Most publications on Xpert MTB/RIF or CBNAAT
have been from Sub-Saharan Africa [6, 8–10, 13, 16, 17].
India is a TB high burden country and the central TB
division of India, which has been bestowed the responsi-
bility of implementing the revised national TB control
programme has recently installed more than 80 CBNAAT
Fig. 2 Individual and overlap analysis of Xpert MTB/RIF positivity in gastric aspirate and induced sputum samples collected on 2 consecutive days
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Table 4 Sensitivity, specificity and predictive values of Xpert MTB/RIF assay in reference to AFB smear and Bactec-MGIT960 culture in induced sputum (n = 260) vs. gastric aspirate
(n = 260) samples
Sensitivity Specificity PPV NPV LRF of positive test Diagnostic accuracy Sensitivity
(smear positive)
Sensitivity
(smear negative)
Xpert MTB/RIF assay vs Culture
Induced Sputum 35/50 (70.0 %; 56.2–80.9)* 198/210 (94.3 %; 90.3–96.7)** 74.5 % (60.5–84.6) 92.7 % (88.7–95.7) 12.2 % (10.2–14.8) 89.6 % (85.3–92.8) 6/6 (100 %) 29/44 (65.9 %)
Gastric Aspirate 52/77 (67.5 %; 56.5–76.9)* 164/183 (89.6 %; 84.3–93.2)** 73.2 % (61.9–82.1) 87.8 % (81.2–90.9) 6.5 % (5.8–7.3) 83.1 % (78.0–87.1) 16/17 (94.1 %) 36/60 (60.0 %)
AFB vs Culture
Induced Sputum 6/50 (12.0 %; 5.6–23.8)*** 210/210 (100 %; 98.2–100) 100 % (60.8–100) 82.7 % (77.5–86.8) - 83.1 % (78.1–87.1) NA NA
Gastric Aspirate 17/77 (22.1 %; 14.3–32.5) 183/183 (100 %; 97.9–100) 100 % (81.6–100) 75.3 % (71.4–81.6) - 76.9 % (71.4–81.6) NA NA
Data n/N (%; 95 % CI) or % (95 % CI), Positive predictive value (PPV), negative predictive value (NPV), Likelihood ratio (LRF), *p = 0.77, **p = 0.087, ***p = 0.792
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machines.. But country specific data and guidelines on
using CBNAAT machines for diagnosing childhood tuber-
culosis are lacking. Our is also the first study wherein we
have used gastric aspirate and induced sputum sample
stored for upto 4.3 years (median storage period of
32.5 months). In smear and culture proven samples it
showed sensitivity of 95.7 % which was within the range
reported by several other workers but only on fresh sam-
ples [10, 17]. In fresh samples a variable value addition of
the Xpert MTB/ RIF over the MGIT culture has been re-
ported, but in our study this value addition was minimal
(7.9 %), probably due to some loss of mycobacterial viabil-
ity on long-term storage of samples [32]. The additional
cases detected over the gold standard culture test, were
very unlikely to be false positive. Mycobacterial counts de-
plete on storage of samples even after few days (30) but
contradictory observations have also been made by other
workers [33, 34]. Paramasivan et al. [33] reported that
there was no effect on the sensitivity rates of smear and
culture after storing the sputum samples upto 10 days.
Tessema et al. [34] have reported that storage of sputum
samples upto 80 days at room temperature and in frozen
samples upto 180 days had no negative effect on culture
yield. Banda et al. [35] observed that sputum samples
remained smear positive upto 8 weeks, and culture posi-
tivity was 54–67 % after 4 weeks of storage under frozen
conditions but the positivity rate went down to 37–39 % if
the samples were stored at room temperature. There are
no previous reports on the effect of long term storage on
the sensitivity of Xpert MTB/RIF on GA and IS samples.
Smear positive samples carry high bacillary (>10000 bacilli
/ml) counts, which presumably means that samples having
a count of more than 104 bacilli/ml will have sufficient
counts detectable by Xpert MTB/RIF even after several
years. TB control programmes can therefore, retrospect-
ively trace the real-time incidence and rise in MDR-TB
rates in specific areas or countries, using the exact dates
of archiving the samples and correlating the epidemio-
logical pattern and emergence of MDR-TB in those coun-
tries. The results from this study can contribute to
providing such a data for India. Furthermore, this
study is the first to evaluate the Xpert MTB/RIF on a
large number of representative samples which include a
paired GA and IS sample collected on two consecutive
days on children with intrathoracic TB.
Xpert MTB/RIF showed high specificity for NTM
positive samples as did our in-house PCR. But in com-
parison with the in-house m-PCR, Xpert MTB/RIF
missed one M. tuberculosis isolate (flow chart). We are
analyzing this isolate, to determine if the isolate has a
unique mutation in rpoB gene which inhibited amplifica-
tion of this gene [36]. We conclude that the Xpert
MTB/RIF assay is reliable test for rapid and correctly
diagnosing pulmonary tuberculosis in children using GA
and IS samples, preferably in multiple samples. Further-
more, the assay can also be used in retrospective testing
of samples stored for at least 4.5 years with acceptable
diagnostic sensitivity and detection of RIF resistance.
Conclusions
Combination of 2 gastric aspirates and 2 induced spu-
tum samples collected on two consecutive days, and
three diagnostic methods i.e. smear examination, liquid
culture and Xpert MTB/RIF, yielded a very high TB
detection rate. Overall and per patient detection rate of
BACTEC-MGIT culture was 24.4 and 46.9 %, respectively.
Fig. 3 Declining positivity rates in the Xpert MTB/RIF assay in relation to duration of storage of gastric aspirate and induced sputum samples
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Though there was no significant difference in the diagnos-
tic yield of samples collected on day 1 and day 2, but a
combination of GA and IS yielded best results. Despite
long term storage, the overall sensitivity of Xpert MTB/
RIF on smear and -culture positive samples were 95.6 %.
In smear negative and culture positive samples the
sensitivity of Xpert MTB/RIF was 62.5 %. But in
bacteriologically confirmed samples, as expected, the
detection rate was higher (68.5 %). The TB detection
rate of smear microscopy, culture and Xpert MTB/
RIF assay was also higher in GA samples than in IS
samples. To our knowledge, this is the first report
which shows that smear and culture positive samples
stored at subfreezing conditions for upto 3.5 years can be
used in Xpert MTB/RIF assay without a significant effect
on the diagnostic sensitivity and specificity of the test.
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